Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, OncoCyte (OCX) has a market cap of $32.997 million USD. According to our data, OncoCyte is ranked No.8371 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $33.00 M |
-17.65%
|
| Dec 31, 2024 | $40.07 M |
-4.80%
|
| Dec 29, 2023 | $42.09 M |
-61.06%
|
| Dec 30, 2022 | $0.11 B |
-85.21%
|
| Dec 31, 2021 | $0.73 B |
-9.21%
|
| Dec 31, 2020 | $0.80 B |
6.22%
|
| Dec 31, 2019 | $0.76 B |
63.04%
|
| Dec 31, 2018 | $0.46 B |
-70.32%
|
| Dec 29, 2017 | $1.57 B |
-34.04%
|
| Dec 30, 2016 | $2.37 B |
12.80%
|
| Dec 31, 2015 | $2.10 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
 Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
 Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
 NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
 Fulgent Genetics
FLGT
|
$0.52 B |
-0.000 M
|
USA
|
 Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
 Veracyte
VCYT
|
$3.34 B |
-0.000 M
|
USA
|
 Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
 Personalis
PSNL
|
$0.47 B |
0.000 M
|
USA
|
 Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
 Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
 QuidelOrtho
QDEL
|
$2.99 B |
-0.000 M
|
USA
|
| Market Cap | = | OCX Stock Price | * | OCX Shares Outstanding |
| = | $1.96 | * | 16.84 M | |
| = | $33.00 M |